Intracytoplasmic Sperm Injection (ICSI), Embryo Transfer, Maternal BMI and Oocyte Quality: Implications for IVF Protocol Study on Live Birth Outcomes

Infertility is becoming an increasingly common reproductive health condition globally, leading to a dramatic increase in the use of assisted reproductive technologies, including intracytoplasmic sperm injection (ICSI) and in vitro fertilisation (IVF). Numerous factors, such as the mother, the embryo, and the IVF procedure, contribute to the success rate of in vitro fertilisation (IVF) and live births. Investigated here are in vitro fertilisation (IVF) success rates as a function of oocyte quality, maternal body mass index (BMI), embryo transfer methods, and ICSI. Female infertility patients undergoing in vitro fertilisation procedures at assisted reproduction centres were the subjects of the study, which used a quantitative methodology. Embryonic factors were considered alongside age, BMI, oocyte shape, fertilisation, embryo growth, embryo implantation rate, and pregnancy success rates. A chi-square test, descriptive statistics, regression models, and correlation analyses were all used to analyse the data statistically. The results show that the mother's oocyte quality and body mass index (BMI) significantly affect live birth rates, embryo growth, embryo implantation rate, and fertilisation success. There was a correlation between poor oocyte quality and high maternal BMI, lower rates of IVF success, and lower chances of live births.